T17	B-Entity	0	2	NF	NF	B-NP	NN	B-protein	3	NMOD	B-protein
T17	I-Entity	2	3	-	-	I-NP	HYPH	I-protein	3	NMOD	I-protein
T17	I-Entity	3	9	kappaB	kappaB	I-NP	NN	I-protein	4	SUB	I-protein
O	O	10	19	regulates	regulate	B-VP	VBZ	O	0	ROOT	O
T1	B-Protein	20	23	Fas	Fas	B-NP	NN	B-protein	11	NMOD	B-protein
O	O	23	24	/	/	B-NP	SYM	O	11	P	O
T2	B-Protein	24	27	APO	APO	I-NP	NN	B-protein	11	NMOD	B-protein
T2	I-Protein	27	28	-	-	B-NP	SYM	I-protein	11	NMOD	I-protein
T2	I-Protein	28	29	1	1	I-NP	CD	I-protein	11	NMOD	I-protein
O	O	29	30	/	/	I-NP	SYM	O	11	NMOD	O
T3	B-Protein	30	34	CD95	CD95	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	34	35	-	-	B-NP	HYPH	O	11	P	O
O	O	36	39	and	and	I-NP	CC	O	11	NMOD	O
T18	B-Entity	40	43	TCR	TCR	I-NP	NN	B-protein	4	OBJ	B-protein
O	O	43	44	-	-	O	HYPH	O	14	P	O
O	O	45	53	mediated	mediate	B-NP	VBN	O	17	NMOD	O
O	O	54	63	apoptosis	apoptosis	I-NP	NN	O	14	NMOD	O
O	O	64	66	of	of	B-PP	IN	O	14	NMOD	O
O	O	67	68	T	T	B-NP	NN	B-cell_type	20	NMOD	B-cell_type
O	O	69	80	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	80	81	.	.	O	.	O	4	P	O

O	O	83	86	The	The	B-NP	DT	O	2	NMOD	O
O	O	87	98	maintenance	maintenance	I-NP	NN	O	8	SUB	O
O	O	99	101	of	of	B-PP	IN	O	2	NMOD	O
O	O	102	112	lymphocyte	lymphocyte	B-NP	NN	O	5	NMOD	O
O	O	113	124	homeostasis	homeostasis	I-NP	NN	O	3	PMOD	O
O	O	125	127	by	by	B-PP	IN	O	2	NMOD	O
O	O	128	137	apoptosis	apoptosis	B-NP	NN	O	6	PMOD	O
O	O	138	140	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	141	142	a	a	B-NP	DT	O	12	NMOD	O
O	O	143	151	critical	critical	I-NP	JJ	O	12	NMOD	O
O	O	152	162	regulatory	regulatory	I-NP	JJ	O	12	NMOD	O
O	O	163	172	mechanism	mechanism	I-NP	NN	O	8	PRD	O
O	O	173	175	in	in	B-PP	IN	O	12	NMOD	O
O	O	176	179	the	the	B-NP	DT	O	17	NMOD	O
O	O	180	186	normal	normal	I-NP	JJ	O	17	NMOD	O
O	O	187	193	immune	immune	I-NP	JJ	O	17	NMOD	O
O	O	194	200	system	system	I-NP	NN	O	13	PMOD	O
O	O	200	201	.	.	O	.	O	8	P	O

O	O	202	205	The	The	B-NP	DT	O	3	NMOD	O
O	O	206	219	transcription	transcription	I-NP	NN	B-protein	3	NMOD	B-protein
O	O	220	226	factor	factor	I-NP	NN	I-protein	6	NMOD	I-protein
T19	B-Entity	227	229	NF	NF	I-NP	NN	B-protein	6	NMOD	B-protein
T19	I-Entity	229	230	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T19	I-Entity	230	236	kappaB	kappaB	I-NP	NN	I-protein	7	SUB	I-protein
O	O	237	240	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	241	245	been	be	I-VP	VBN	O	7	VC	O
O	O	246	251	shown	show	I-VP	VBN	O	8	VC	O
O	O	252	254	to	to	I-VP	TO	O	11	VMOD	O
O	O	255	259	play	play	I-VP	VB	O	9	VMOD	O
O	O	260	261	a	a	B-NP	DT	O	13	NMOD	O
O	O	262	266	role	role	I-NP	NN	O	11	OBJ	O
O	O	267	269	in	in	B-PP	IN	O	11	VMOD	O
O	O	270	280	protecting	protect	B-VP	VBG	O	14	PMOD	O
O	O	281	286	cells	cell	B-NP	NNS	O	15	OBJ	O
O	O	287	294	against	against	B-PP	IN	O	15	VMOD	O
O	O	295	300	death	death	B-NP	NN	O	17	PMOD	O
O	O	301	309	mediated	mediate	B-VP	VBN	O	18	NMOD	O
O	O	310	312	by	by	B-PP	IN	O	19	VMOD	O
O	O	313	316	TNF	TNF	B-NP	NN	B-protein	20	PMOD	B-protein
O	O	317	319	We	We	B-NP	PRP	O	23	SUB	O
O	O	320	324	show	show	B-VP	VBP	O	14	SBAR	O
O	O	325	329	here	here	B-ADVP	RB	O	23	VMOD	O
O	O	330	334	that	that	B-SBAR	IN	O	23	VMOD	O
T20	B-Entity	335	337	NF	NF	B-NP	NN	B-protein	28	NMOD	B-protein
T20	I-Entity	337	338	-	-	O	HYPH	I-protein	28	NMOD	I-protein
T20	I-Entity	338	344	kappaB	kappaB	B-NP	NN	I-protein	30	SUB	I-protein
O	O	345	349	also	also	B-ADVP	RB	O	30	VMOD	O
O	O	350	353	has	have	B-VP	VBZ	O	25	SBAR	O
O	O	354	355	a	a	B-NP	DT	O	32	NMOD	O
O	O	356	360	role	role	I-NP	NN	O	30	OBJ	O
O	O	361	363	in	in	B-PP	IN	O	30	VMOD	O
O	O	364	374	regulating	regulate	B-VP	VBG	O	33	PMOD	O
T4	B-Protein	375	378	Fas	Fas	B-NP	NN	B-protein	41	NMOD	B-protein
O	O	378	379	/	/	B-NP	SYM	O	41	P	O
T5	B-Protein	379	382	APO	APO	I-NP	NN	B-protein	41	NMOD	B-protein
T5	I-Protein	382	383	-	-	B-NP	SYM	I-protein	41	NMOD	I-protein
T5	I-Protein	383	384	1	1	I-NP	CD	I-protein	41	NMOD	I-protein
O	O	384	385	/	/	I-NP	SYM	O	41	P	O
T6	B-Protein	385	389	CD95	CD95	I-NP	NN	B-protein	44	NMOD	B-protein
O	O	389	390	-	-	O	HYPH	O	41	P	O
O	O	390	398	mediated	mediate	B-NP	VBN	O	44	NMOD	O
O	O	399	404	death	death	I-NP	NN	O	34	OBJ	O
O	O	404	405	,	,	O	,	O	30	P	O
O	O	406	407	a	a	B-NP	DT	O	48	NMOD	O
O	O	408	413	major	major	I-NP	JJ	O	48	NMOD	O
O	O	414	421	pathway	pathway	I-NP	NN	O	30	OBJ	O
O	O	422	424	of	of	B-PP	IN	O	48	NMOD	O
O	O	425	435	peripheral	peripheral	B-NP	JJ	B-cell_type	53	NMOD	B-cell_type
O	O	436	437	T	T	I-NP	NN	I-cell_type	53	NMOD	I-cell_type
O	O	438	442	cell	cell	I-NP	NN	I-cell_type	53	NMOD	I-cell_type
O	O	443	448	death	death	I-NP	NN	O	49	PMOD	O
O	O	448	449	.	.	O	.	O	7	P	O

O	O	450	462	Transfection	Transfection	B-NP	NN	O	14	SUB	O
O	O	463	465	of	of	B-PP	IN	O	1	NMOD	O
O	O	466	472	Jurkat	Jurkat	B-NP	NN	B-cell_line	4	NMOD	B-cell_line
O	O	473	478	cells	cell	I-NP	NNS	I-cell_line	2	PMOD	I-cell_line
O	O	479	483	with	with	B-PP	IN	O	1	NMOD	O
O	O	484	487	the	the	B-NP	DT	O	10	NMOD	O
O	O	488	490	NF	NF	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	490	491	-	-	O	HYPH	I-protein	10	NMOD	I-protein
O	O	491	497	kappaB	kappaB	B-NP	NN	I-protein	10	NMOD	I-protein
O	O	498	506	subunits	subunit	I-NP	NNS	I-protein	13	NMOD	I-protein
T7	B-Protein	507	510	p50	p50	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	511	514	and	and	O	CC	O	13	NMOD	O
T8	B-Protein	515	518	p65	p65	B-NP	NN	B-protein	5	PMOD	B-protein
O	O	519	526	confers	confer	B-VP	VBZ	O	0	ROOT	O
O	O	527	537	resistance	resistance	B-NP	NN	O	14	OBJ	O
O	O	538	545	against	against	B-PP	IN	O	15	NMOD	O
T9	B-Protein	546	549	Fas	Fas	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	549	550	-	-	B-NP	HYPH	O	20	NMOD	O
O	O	550	558	mediated	mediate	I-NP	VBN	O	20	NMOD	O
O	O	559	568	apoptosis	apoptosis	I-NP	NN	O	16	PMOD	O
O	O	568	569	.	.	O	.	O	14	P	O

O	O	570	582	Reciprocally	Reciprocally	B-ADVP	RB	O	27	VMOD	O
O	O	582	583	,	,	O	,	O	27	P	O
O	O	584	594	inhibition	inhibition	B-NP	NN	O	27	SUB	O
O	O	595	597	of	of	B-PP	IN	O	3	NMOD	O
T21	B-Entity	598	600	NF	NF	B-NP	NN	B-protein	7	NMOD	B-protein
T21	I-Entity	600	601	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
T21	I-Entity	601	607	kappaB	kappaB	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	608	618	activation	activation	I-NP	NN	O	4	PMOD	O
O	O	619	621	by	by	B-PP	IN	O	3	NMOD	O
O	O	622	623	a	a	B-NP	DT	O	13	NMOD	O
T22	B-Entity	624	631	soluble	soluble	I-NP	JJ	O	13	NMOD	O
T22	I-Entity	632	639	peptide	peptide	I-NP	NN	O	13	NMOD	O
T22	I-Entity	640	649	inhibitor	inhibitor	I-NP	NN	O	17	NMOD	O
O	O	650	652	or	or	O	CC	O	17	NMOD	O
O	O	653	654	a	a	B-NP	DT	O	17	NMOD	O
O	O	655	663	dominant	dominant	I-NP	JJ	O	17	NMOD	O
O	O	664	668	form	form	I-NP	NN	O	9	PMOD	O
O	O	669	671	of	of	B-PP	IN	O	17	NMOD	O
O	O	672	675	the	the	B-NP	DT	O	23	NMOD	O
T23	B-Entity	676	678	NF	NF	I-NP	NN	B-protein	23	NMOD	B-protein
T23	I-Entity	678	679	-	-	B-NP	HYPH	I-protein	23	NMOD	I-protein
T23	I-Entity	679	685	kappaB	kappaB	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	686	695	inhibitor	inhibitor	I-NP	NN	O	25	NMOD	O
O	O	695	696	,	,	O	,	O	25	P	O
O	O	697	704	IkappaB	IkappaB	B-NP	NN	B-protein	18	PMOD	B-protein
O	O	704	705	,	,	O	,	O	3	P	O
O	O	706	711	makes	make	B-VP	VBZ	O	0	ROOT	O
O	O	712	715	the	the	B-NP	DT	O	29	NMOD	O
O	O	716	721	cells	cell	I-NP	NNS	O	31	SUB	O
O	O	722	726	more	more	B-ADJP	RBR	O	31	AMOD	O
O	O	727	738	susceptible	susceptible	I-ADJP	JJ	O	36	NMOD	O
O	O	739	741	to	to	B-PP	TO	O	31	AMOD	O
T10	B-Protein	742	745	Fas	Fas	B-NP	NN	B-protein	32	PMOD	B-protein
O	O	745	746	-	-	O	HYPH	O	31	P	O
O	O	746	754	mediated	mediate	B-NP	VBN	O	36	NMOD	O
O	O	755	764	apoptosis	apoptosis	I-NP	NN	O	27	OBJ	O
O	O	764	765	.	.	O	.	O	27	P	O

O	O	766	777	Furthermore	Furthermore	B-ADVP	RB	O	14	VMOD	O
O	O	777	778	,	,	O	,	O	14	P	O
O	O	779	789	inhibition	inhibition	B-NP	NN	O	14	SUB	O
O	O	790	792	of	of	B-PP	IN	O	3	NMOD	O
T24	B-Entity	793	795	NF	NF	B-NP	NN	B-protein	7	NMOD	B-protein
T24	I-Entity	795	796	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
T24	I-Entity	796	802	kappaB	kappaB	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	803	813	activation	activation	I-NP	NN	O	4	PMOD	O
O	O	814	816	by	by	B-PP	IN	O	3	NMOD	O
O	O	817	818	a	a	B-NP	DT	O	13	NMOD	O
T25	B-Entity	819	826	soluble	soluble	I-NP	JJ	O	13	NMOD	O
T25	I-Entity	827	834	peptide	peptide	I-NP	NN	O	13	NMOD	O
T25	I-Entity	835	844	inhibitor	inhibitor	I-NP	NN	O	9	PMOD	O
O	O	845	853	rendered	render	B-VP	VBD	O	0	ROOT	O
O	O	854	855	a	a	B-NP	DT	O	18	NMOD	O
O	O	856	857	T	T	I-NP	NN	B-cell_line	18	NMOD	B-cell_line
O	O	858	862	cell	cell	I-NP	NN	I-cell_line	18	NMOD	I-cell_line
O	O	863	872	hybridoma	hybridoma	I-NP	NN	I-cell_line	20	SUB	I-cell_line
O	O	873	877	more	more	B-ADJP	RBR	O	20	AMOD	O
O	O	878	889	susceptible	susceptible	I-ADJP	JJ	O	14	VMOD	O
O	O	890	892	to	to	B-PP	TO	O	20	AMOD	O
T26	B-Entity	893	896	TCR	TCR	B-NP	NN	B-protein	25	NMOD	B-protein
O	O	896	897	-	-	O	HYPH	O	22	P	O
O	O	897	905	mediated	mediate	B-NP	VBN	O	25	NMOD	O
O	O	906	915	apoptosis	apoptosis	I-NP	NN	O	21	PMOD	O
O	O	915	916	.	.	O	.	O	14	P	O

O	O	917	932	Correspondingly	Correspondingly	B-ADVP	RB	O	8	VMOD	O
O	O	932	933	,	,	O	,	O	8	P	O
O	O	934	946	transfection	transfection	B-NP	NN	O	8	SUB	O
O	O	947	949	of	of	B-PP	IN	O	3	NMOD	O
T11	B-Protein	950	953	p50	p50	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	954	957	and	and	O	CC	O	7	NMOD	O
T12	B-Protein	958	961	p65	p65	B-NP	NN	B-protein	4	PMOD	B-protein
O	O	962	970	provided	provide	B-VP	VBD	O	0	ROOT	O
O	O	971	983	considerable	considerable	B-NP	JJ	O	10	NMOD	O
O	O	984	994	protection	protection	I-NP	NN	O	8	OBJ	O
O	O	995	999	from	from	B-PP	IN	O	10	NMOD	O
T27	B-Entity	1000	1003	TCR	TCR	B-NP	NN	B-protein	15	NMOD	B-protein
O	O	1003	1004	-	-	B-NP	HYPH	O	12	P	O
O	O	1004	1012	mediated	mediate	I-NP	VBN	O	12	AMOD	O
O	O	1013	1022	apoptosis	apoptosis	I-NP	NN	O	11	PMOD	O
O	O	1022	1023	.	.	O	.	O	8	P	O

O	O	1024	1029	These	These	B-NP	DT	O	2	NMOD	O
O	O	1030	1042	observations	observation	I-NP	NNS	O	3	SUB	O
O	O	1043	1047	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1048	1060	corroborated	corroborate	I-VP	VBN	O	3	VC	O
O	O	1061	1063	by	by	B-PP	IN	O	4	VMOD	O
O	O	1064	1071	studies	study	B-NP	NNS	O	5	PMOD	O
O	O	1072	1074	on	on	B-PP	IN	O	6	NMOD	O
T13	B-Protein	1075	1078	Fas	Fas	B-NP	NN	B-protein	11	NMOD	B-protein
O	O	1078	1079	-	-	B-NP	HYPH	O	11	NMOD	O
O	O	1079	1087	mediated	mediate	I-NP	VBN	O	11	NMOD	O
O	O	1088	1093	death	death	I-NP	NN	O	7	PMOD	O
O	O	1094	1096	in	in	B-PP	IN	O	11	NMOD	O
O	O	1097	1104	primary	primary	B-NP	JJ	B-cell_type	15	NMOD	B-cell_type
O	O	1105	1106	T	T	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	1107	1112	cells	cell	I-NP	NNS	I-cell_type	12	PMOD	I-cell_type
O	O	1112	1113	.	.	O	.	O	3	P	O

O	O	1114	1126	Concanavalin	Concanavalin	B-NP	NN	O	2	NMOD	O
O	O	1127	1128	A	A	I-NP	NN	O	19	SUB	O
O	O	1128	1129	-	-	O	HYPH	O	2	P	O
O	O	1129	1138	activated	activate	B-VP	VBN	O	2	NMOD	O
O	O	1139	1146	cycling	cycle	B-VP	VBG	O	4	VMOD	O
O	O	1147	1148	T	T	B-NP	NN	B-cell_type	8	NMOD	B-cell_type
O	O	1149	1153	cell	cell	I-NP	NN	I-cell_type	8	NMOD	I-cell_type
O	O	1154	1160	blasts	blast	I-NP	NNS	I-cell_type	5	OBJ	I-cell_type
O	O	1161	1165	from	from	B-PP	IN	O	5	VMOD	O
O	O	1166	1170	mice	mouse	B-NP	NNS	O	9	PMOD	O
O	O	1171	1175	that	that	B-NP	WDT	O	10	NMOD	O
O	O	1176	1179	are	be	B-VP	VBP	O	11	SBAR	O
O	O	1180	1190	transgenic	transgenic	B-ADJP	JJ	O	12	PRD	O
O	O	1191	1194	for	for	B-PP	IN	O	13	AMOD	O
O	O	1195	1198	the	the	B-NP	DT	O	18	NMOD	O
O	O	1199	1207	dominant	dominant	I-NP	JJ	B-protein	18	NMOD	B-protein
O	O	1208	1215	IkappaB	IkappaB	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	1216	1224	molecule	molecule	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	1225	1229	have	have	B-VP	VBP	O	0	ROOT	O
O	O	1230	1239	increased	increase	I-VP	VBN	O	19	VC	O
O	O	1240	1251	sensitivity	sensitivity	B-NP	NN	O	20	OBJ	O
O	O	1252	1254	to	to	B-PP	TO	O	21	NMOD	O
T14	B-Protein	1255	1258	Fas	Fas	B-NP	NN	B-protein	26	NMOD	B-protein
O	O	1258	1259	-	-	B-NP	HYPH	O	26	NMOD	O
O	O	1259	1267	mediated	mediate	I-NP	VBN	O	26	NMOD	O
O	O	1268	1277	apoptosis	apoptosis	I-NP	NN	O	22	PMOD	O
O	O	1277	1278	,	,	O	,	O	20	P	O
O	O	1279	1289	associated	associate	B-VP	VBN	O	20	VMOD	O
O	O	1290	1294	with	with	B-PP	IN	O	28	VMOD	O
O	O	1295	1296	a	a	B-NP	DT	O	33	NMOD	O
O	O	1297	1301	down	down	I-NP	RB	O	32	AMOD	O
O	O	1301	1302	-	-	I-NP	HYPH	O	33	NMOD	O
O	O	1302	1312	regulation	regulation	B-NP	NN	O	29	PMOD	O
O	O	1313	1315	of	of	B-PP	IN	O	33	NMOD	O
T28	B-Entity	1316	1318	NF	NF	B-NP	NN	B-protein	38	NMOD	B-protein
T28	I-Entity	1318	1319	-	-	B-NP	HYPH	I-protein	38	NMOD	I-protein
T28	I-Entity	1319	1325	kappaB	kappaB	I-NP	NN	I-protein	38	NMOD	I-protein
T28	I-Entity	1326	1335	complexes	complex	I-NP	NNS	I-protein	34	PMOD	I-protein
O	O	1336	1338	in	in	B-PP	IN	O	33	NMOD	O
O	O	1339	1342	the	the	B-NP	DT	O	41	NMOD	O
O	O	1343	1350	nucleus	nucleus	I-NP	NN	O	39	PMOD	O
O	O	1350	1351	.	.	O	.	O	19	P	O

O	O	1352	1354	In	In	B-PP	IN	O	19	VMOD	O
O	O	1355	1363	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	1363	1364	,	,	O	,	O	19	P	O
O	O	1365	1373	blocking	block	B-VP	VBG	O	19	SUB	O
O	O	1374	1377	TNF	TNF	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	1377	1378	,	,	O	,	O	10	P	O
O	O	1379	1385	itself	itself	B-NP	PRP	O	10	NMOD	O
O	O	1386	1387	a	a	B-NP	DT	O	10	NMOD	O
O	O	1388	1396	positive	positive	I-NP	JJ	B-protein	10	NMOD	B-protein
O	O	1397	1406	regulator	regulator	I-NP	NN	I-protein	4	OBJ	I-protein
O	O	1407	1409	of	of	B-PP	IN	O	10	NMOD	O
T29	B-Entity	1410	1412	NF	NF	B-NP	NN	B-protein	14	NMOD	B-protein
T29	I-Entity	1412	1413	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
T29	I-Entity	1413	1419	kappaB	kappaB	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	1419	1420	,	,	O	,	O	4	P	O
O	O	1421	1425	with	with	B-PP	IN	O	4	VMOD	O
O	O	1426	1438	neutralizing	neutralize	B-NP	VBG	B-protein	18	NMOD	B-protein
O	O	1439	1449	antibodies	antibody	I-NP	NNS	I-protein	16	PMOD	I-protein
O	O	1450	1457	renders	render	B-VP	VBZ	O	0	ROOT	O
O	O	1458	1461	the	the	B-NP	DT	O	21	NMOD	O
O	O	1462	1467	cells	cell	I-NP	NNS	O	23	SUB	O
O	O	1468	1472	more	more	B-ADJP	RBR	O	23	AMOD	O
O	O	1473	1484	susceptible	susceptible	I-ADJP	JJ	O	19	VMOD	O
O	O	1485	1487	to	to	B-PP	TO	O	23	AMOD	O
O	O	1488	1492	anti	anti	B-NP	AFX	O	30	NMOD	O
O	O	1492	1493	-	-	I-NP	HYPH	O	30	NMOD	O
T15	B-Protein	1493	1496	Fas	Fas	I-NP	NN	B-protein	30	NMOD	B-protein
O	O	1496	1497	-	-	O	HYPH	O	30	NMOD	O
O	O	1497	1505	mediated	mediate	B-NP	VBN	O	30	NMOD	O
O	O	1506	1515	apoptosis	apoptosis	I-NP	NN	O	24	PMOD	O
O	O	1515	1516	.	.	O	.	O	19	P	O

O	O	1517	1519	In	In	B-PP	IN	O	6	VMOD	O
O	O	1520	1527	summary	summary	B-NP	NN	O	1	PMOD	O
O	O	1527	1528	,	,	O	,	O	6	P	O
O	O	1529	1532	our	our	B-NP	PRP$	O	5	NMOD	O
O	O	1533	1540	results	result	I-NP	NNS	O	6	SUB	O
O	O	1541	1548	provide	provide	B-VP	VBP	O	0	ROOT	O
O	O	1549	1559	compelling	compelling	B-NP	JJ	O	8	NMOD	O
O	O	1560	1568	evidence	evidence	I-NP	NN	O	6	OBJ	O
O	O	1569	1573	that	that	B-SBAR	IN	O	8	NMOD	O
T30	B-Entity	1574	1576	NF	NF	B-NP	NN	B-protein	12	NMOD	B-protein
T30	I-Entity	1576	1577	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
T30	I-Entity	1577	1583	kappaB	kappaB	I-NP	NN	I-protein	13	SUB	I-protein
O	O	1584	1592	protects	protect	B-VP	VBZ	O	9	SBAR	O
O	O	1593	1600	against	against	B-PP	IN	O	13	VMOD	O
T16	B-Protein	1601	1604	Fas	Fas	B-NP	NN	B-protein	14	PMOD	B-protein
O	O	1604	1605	-	-	O	HYPH	O	13	P	O
O	O	1605	1613	mediated	mediate	B-NP	VBN	O	18	NMOD	O
O	O	1614	1619	death	death	I-NP	NN	O	13	OBJ	O
O	O	1620	1623	and	and	O	CC	O	13	VMOD	O
O	O	1624	1626	is	be	B-VP	VBZ	O	13	VMOD	O
O	O	1627	1633	likely	likely	B-ADJP	JJ	O	20	PRD	O
O	O	1634	1636	to	to	B-VP	TO	O	23	VMOD	O
O	O	1637	1639	be	be	I-VP	VB	O	21	AMOD	O
O	O	1640	1642	an	an	B-NP	DT	O	26	NMOD	O
O	O	1643	1652	important	important	I-NP	JJ	O	26	NMOD	O
O	O	1653	1662	regulator	regulator	I-NP	NN	O	23	PRD	O
O	O	1663	1665	of	of	B-PP	IN	O	26	NMOD	O
O	O	1666	1667	T	T	B-NP	NN	O	30	NMOD	O
O	O	1668	1672	cell	cell	I-NP	NN	O	30	NMOD	O
O	O	1673	1684	homeostasis	homeostasis	I-NP	NN	O	32	NMOD	O
O	O	1685	1688	and	and	I-NP	CC	O	32	NMOD	O
O	O	1689	1698	tolerance	tolerance	I-NP	NN	O	27	PMOD	O
O	O	1698	1699	.	.	O	.	O	6	P	O
